PMC:7441788 / 18034-18304 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T229","span":{"begin":2,"end":7},"obj":"Chemical"},{"id":"T230","span":{"begin":179,"end":188},"obj":"Chemical"}],"attributes":[{"id":"A229","pred":"chebi_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A230","pred":"chebi_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"l group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to s"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T9","span":{"begin":53,"end":65},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A9","pred":"meddra_id","subj":"T9","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062026"}],"text":"l group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to s"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"645","span":{"begin":248,"end":256},"obj":"Species"},{"id":"674","span":{"begin":201,"end":204},"obj":"Chemical"}],"attributes":[{"id":"A645","pred":"pubann:denotes","subj":"645","obj":"Tax:9606"},{"id":"A674","pred":"pubann:denotes","subj":"674","obj":"MESH:D006886"}],"text":"l group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to s"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T120","span":{"begin":179,"end":188},"obj":"http://purl.obolibrary.org/obo/IDO_0000559"}],"text":"l group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to s"}

{"project":"LitCovid-PubTator","denotations":[{"id":"645","span":{"begin":248,"end":256},"obj":"Species"},{"id":"674","span":{"begin":201,"end":204},"obj":"Chemical"}],"attributes":[{"id":"A645","pred":"tao:has_database_id","subj":"645","obj":"Tax:9606"},{"id":"A674","pred":"tao:has_database_id","subj":"674","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"l group; Design introduces the possibility of biased investigator determined assessment and unbalanced dosage adjustment; Randomization of sequential envelopes may be biased. The antiviral efficacy of HCQ was not assessed at an earlier stage; Most patients are mild to s"}